Allos Therapeutics (ALTH) Tops Q4 EPS by 6c
Tweet
Share
E-mailGet Alerts ALTH Hot Sheet
Price: $1.84 --0%
Financial Fact:
Interest and other income, net: 4K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest and other income, net: 4K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Allos Therapeutics (NASDAQ: ALTH) reported Q4 EPS of ($0.01), $0.06 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $15.4 million versus the consensus estimate of $15.94 million.
For earnings history and earnings-related data on Allos Therapeutics (ALTH) click here.
For earnings history and earnings-related data on Allos Therapeutics (ALTH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Vireo Growth completes acquisition of C21 Investments
- BMO starts chip stocks coverage: Here are its preferred picks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
